CPL @1094 (77.7%) on 31-dec-2017 [ "pharmaceutical companies like _" "_ s paxil" "you purchase is manufactured by _" "_ 's Advair" "medication is manufactured by _" "medication you purchase is manufactured by _" "collaboration agreement with _" "_ is a research-based pharmaceutical company" "drug made by _" "pharmaceutical companies such as _" "tablets manufactured by _" ] using glaxosmithkline
CMC @1098 (99.9%) on 21-jan-2018 [ LASTSUFFIX=lc 3.07116 SUFFIX=lc 3.03862 LAST_WORD=plc 2.97776 LASTPREFIX=pl 2.50220 PREFIX=pl 1.80234 PREFIX=gla 1.39058 PREFIX=glax 1.32561 SHORT_WORDSHAPE=a -1.62156 SUFFIX=ine -2.49292 WORDS -7.98990 ] using glaxosmithkline_plc
OE @823 (87.7%) on 17-mar-2014 [ ] using glaxosmithkline
SEAL @241 (52.6%) on 22-apr-2011 [ 1 ] using glaxosmithkline_plc
CPL @1097 (83.5%) on 19-jan-2018 [ "name drug made by _" "drug made by _" "drug , made by _" "detailed dividend stock ratings information for _" "treatment sold by _" "Ratings information for _" "_ 's Levitra" "antidepressant made by _" "Japanese subsidiary of _" "Dividend Stock Ratings information for _" "drug companies like _" "_ has asked the FDA" "vaccine developed by _" "_ 's Boniva" "drugs made by _" "stock ratings information for _" "_ 's Cervarix" "ratings information for _" "_ 's Lamictal" "_ 's Paxil" "_ 's Wellbutrin" "_ 's diabetes drug Avandia" "pharmaceutical companies like _" "_ 's Advair" "dividend stock ratings information for _" "drug manufactured by _" "_ 's Avandia" "drug marketed by _" "drug sold by _" "business unit of _" "Stock Ratings information for _" "_ 's Zyban" "_ 's Serevent" "cancer drug from _" "Plavix , made by _" "brand name drug made by _" "vaccine , made by _" ] using glaxosmithkline_plc
CPL @1103 (68.1%) on 08-mar-2018 [ "pharmaceutical companies like _" "trademarks of _" "companies like _" "firms such as _" "companies , such as _" "companies such as _" ] using glaxosmithkline
SEAL @47 (87.5%) on 05-feb-2010 [ 123 ] using glaxosmithkline
CMC @1107 (100.0%) on 24-may-2018 [ SUFFIX=lc 6.86186 LASTSUFFIX=lc 4.12791 LAST_WORD=plc 3.26078 POS=NN 2.25777 SUFFIX=line 1.86679 PREFIX=glax 1.53710 SUFFIX=kline 1.42943 WORDS -1.39097 SUFFIX=ne -1.51428 FULL_POS=NN_NN -2.06218 ] using glaxosmithkline_plc
MBL @1116 (96.9%) on 12-sep-2018 [ Promotion of ceo:andrew_witty ceoof biotechcompany:glaxosmithkline ] using concept:ceo:andrew_witty
LE @1075 (51.4%) on 02-sep-2017
NELL has only weak evidence for items listed in grey
PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:controlledbyagent" "Y~X0~concept:agentcontrols" "Y~_X0~concept:agentcontrols" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof" ] using (andrew_witty, glaxosmithkline)
SEAL @458 (50.0%) on 23-nov-2011 [ 1 ] using (glaxosmithkline, andrew_witty)
SEAL @458 (50.0%) on 23-nov-2011 [ 1 ] using (andrew_witty, glaxosmithkline)
CPL @1095 (93.8%) on 17-jan-2018 [ "arg1 chief executive officer arg2" "arg1 chief executive Sir arg2" "arg1 chief Sir arg2" "arg1 chief executive arg2" ] using (glaxosmithkline, andrew_witty)
PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:controlledbyagent" "Y~X0~concept:agentcontrols" "Y~_X0~concept:agentcontrols" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof" ] using (glaxosmithkline, andrew_witty)
PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:controlledbyagent" "Y~X0~concept:agentcontrols" "Y~_X0~concept:agentcontrols" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof" ] using (andrew_witty, glaxosmithkline)
SEAL @458 (50.0%) on 23-nov-2011 [ 1 ] using (glaxosmithkline, andrew_witty)
SEAL @458 (50.0%) on 23-nov-2011 [ 1 ] using (andrew_witty, glaxosmithkline)
CPL @1095 (93.8%) on 17-jan-2018 [ "arg1 chief executive officer arg2" "arg1 chief executive Sir arg2" "arg1 chief Sir arg2" "arg1 chief executive arg2" ] using (glaxosmithkline, andrew_witty)
PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:controlledbyagent" "Y~X0~concept:agentcontrols" "Y~_X0~concept:agentcontrols" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof" ] using (glaxosmithkline, andrew_witty)
OE @826 (99.0%) on 28-mar-2014 [ ] using (glaxosmithkline, andrew_witty)
PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:agentcollaborateswithagent" "Y~_X0~concept:agentcollaborateswithagent" "Y~X0~concept:agentinteractswithagent" "Y~_X0~concept:agentinteractswithagent" "Y~X0~concept:controlledbyagent" ] using (glaxosmithkline, andrew_witty)
SEAL @331 (99.8%) on 03-jul-2011 [ 123456789 ] using (glaxosmithkline, andrew_witty)
CPL @1095 (87.5%) on 17-jan-2018 [ "arg1 chief executive officer arg2" "arg1 chief executive Sir arg2" "arg1 chief executive arg2" ] using (glaxosmithkline, andrew_witty)
CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 is sold by arg2" ] using (avandia, glaxosmithkline_plc)
CPL @1094 (99.6%) on 01-jan-2018 [ "arg2 under the brand name arg1" "arg2 knew of the dangers of arg1" "arg2 had marketed arg1" "arg2 diabetes drug arg1" "arg2 under the trade name arg1" "arg2 is the manufacturer of arg1" "arg2 has struggled to maintain arg1" "arg2 aggressively marketed arg1" ] using (avandia, glaxosmithkline)
CPL @1094 (99.2%) on 01-jan-2018 [ "arg1 lawsuits filed against arg2" "arg1 is manufactured by arg2" "arg1 and its manufacturer arg2" "arg1 is manufactured arg2" "arg1 CR by arg2" "arg1 was first manufactured by arg2" "arg1 marketed by arg2" ] using (paxil, glaxosmithkline)
SEAL @236 (87.5%) on 16-apr-2011 [ 123 ] using (relenza, glaxosmithkline)
CPL @1094 (87.5%) on 01-jan-2018 [ "arg2 under the brand name arg1" "arg2 under the trade name arg1" "arg2 flu drug arg1" ] using (relenza, glaxosmithkline)
SEAL @566 (93.8%) on 12-may-2012 [ 1234 ] using (glaxosmithkline, andrew_witty)
PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:superpartof" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof,concept:subpartof,concept:superpartof" "Y~X0~concept:controlledbyagent" "Y~_X0~concept:agentcontrols" ] using (andrew_witty, glaxosmithkline)
PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:superpartof" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof,concept:subpartof,concept:superpartof" "Y~X0~concept:controlledbyagent" "Y~_X0~concept:agentcontrols" ] using (glaxosmithkline, andrew_witty)
SEAL @566 (93.8%) on 12-may-2012 [ 1234 ] using (glaxosmithkline, andrew_witty)
PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:superpartof" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof,concept:subpartof,concept:superpartof" "Y~X0~concept:controlledbyagent" "Y~_X0~concept:agentcontrols" ] using (andrew_witty, glaxosmithkline)
PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:superpartof" "Y~X0~concept:superpartof" "Y~_X0~concept:superpartof,concept:subpartof,concept:superpartof" "Y~X0~concept:controlledbyagent" "Y~_X0~concept:agentcontrols" ] using (glaxosmithkline, andrew_witty)
CPL @1099 (93.8%) on 23-jan-2018 [ "arg2 chief executive officer arg1" "arg2 chief executive Sir arg1" "arg2 chief Sir arg1" "arg2 chief executive arg1" ] using (andrew_witty, glaxosmithkline)
PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:agentcontrols,concept:relatedto,concept:agenthierarchicallybelowagent" "Y~X0~concept:agentcontrols,concept:relatedto,concept:controlledbyagent" "Y~X0~concept:agentcontrols,concept:relatedto,concept:agentinteractswithagent" "Y~_X0~concept:proxyfor" "Y~X0~concept:agentcontrols,concept:relatedto,concept:agentcollaborateswithagent" ] using (andrew_witty, glaxosmithkline)
PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentleadsorganization" "Y~_X0~concept:agentrepresentsorganization" "Y~_X0~concept:personleadsorganization" "Y~_X0~concept:mutualproxyfor" "Y~_X0~concept:proxyfor" ] using (andrew_witty, glaxosmithkline)
CPL @1094 (96.9%) on 01-jan-2018 [ "arg2 boss arg1" "arg2 chief executive officer arg1" "arg2 chief executive Sir arg1" "arg2 chief Sir arg1" "arg2 chief executive arg1" ] using (andrew_witty, glaxosmithkline)
PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyperson,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyagent,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:proxyof,concept:personbelongstoorganization" ] using (andrew_witty, glaxosmithkline)
SEAL @190 (99.2%) on 16-jan-2011 [ 1234567 ] using (andrew_witty, glaxosmithkline)
PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:organizationleadbyagent,concept:worksfor,concept:organizationleadbyperson" "Y~X0~concept:organizationhastopmember,concept:worksfor,concept:organizationleadbyperson" "Y~X0~concept:proxyof,concept:worksfor,concept:organizationleadbyperson" "Y~X0~concept:proxyof,concept:subpartof,concept:organizationhasperson" "Y~X0~concept:proxyof,concept:subpartof,concept:worker" ] using (glaxosmithkline, andrew_witty)
PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:worker,concept:agentleadsorganization" "Y~_X0~concept:agentleadsorganization" "Y~_X0~concept:agentrepresentsorganization" "Y~_X0~concept:personleadsorganization" "Y~_X0~concept:agentcontrols" ] using (andrew_witty, glaxosmithkline)
NELL has only weak evidence for items listed in grey